JW Pharmaceutical Corporation announced a private placement of 6,972 registered preferred stock at a price of KRW 57,153 per preferred share for gross proceeds of KRW 398,470,716 on December 3, 2021. The preferred stock is not convertible to equity. The company will issue the securities om third party allotment basis. The company expects to close the transaction on December 13, 2021. The transaction was approved by the board of directors of the company.